Dramatic response of severe headaches to anticoagulation in a patient with antiphospholipid syndrome

Journal of Clinical Rheumatology

Volumn 13, Issue 3, 2007, Pages 173-174

  Asherson, R A ^a,b   Giampaulo, D ^b   Singh, Sham ^c   Sulman, L ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Rosebank Clinic   (South Africa)

^c LANCET LABORATORIES   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; DIPYRIDAMOLE; PHOSPHOLIPID ANTIBODY; SALICYLIC ACID; SUMATRIPTAN SUCCINATE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG WITHDRAWAL; EYE PAIN; FEMALE; HEADACHE; HUMAN; LOW DRUG DOSE; MIGRAINE AURA; NAUSEA; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETINA VEIN; VEIN THROMBOSIS; VISUAL DISORDER;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; WARFARIN;

EID: 34249993511     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3180690af6     Document Type: Article

References (15)

1. Brandt KD, Lessell S. Migrainous phenomena in systemic lupus erythematosus. Arthritis Rheum. 1978;21:7-16.
2. Levine SR, Joseph R, D'Andrea G, et al. Migraine and the lupus anticoagulant. Cephalalgia. 1987;7:93-99.
3. Launey JM, Pradalier A. Common migraine attack: platelet modifications are mainly due to plasma factor(s). Headache. 25:262-268.
4. D'Andrea G, Toldo M, Cortelazzo S, et al. Platelet activity in migraine. Headache. 1982;22:207-212.
5. Dvilansky A, Rishpon S, Nathan I, et al. Release of platelet 5-hydroxytryptamine by plasma taken from patients during and between migraine attacks. Pain. 1976;3:315-318.
6. Damasio H, Beck D. Migraine, thrombocytopenia and serotonin metabolism. Lancet. 1978;i:240-241.
7. Hogan MJ, et al. Lupus anticoagulant, antiphospholipid antibodies and migraine. Can J Neurol Sci. 1988;15:420-425.
8. Shuaib A, Barkley L, Lee MA, et al. Migraine and anti-phospholipid antibodies. Headache. 1989;29:42-45.
9. Silvestsrini M, Matteis M, Troisi E, et al. Migrainous stroke and the antiphospholipid antibodies. Eur Neurol. 1994;34:316-319.
10. Hering R, Couturier EGM, Asherson RA, et al. Antiphosphospholipid antibodies in migraine. Cephalalgia. 1991;11:101-102.
11. Montalban J, Cervera R, Font J, et al. Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus. Neurology. 1992;41:681-682.
12. Fernandez-Nebro A, Palacios-Munoz R, Abarca-Costalgo M, et al. Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study. Lupus. 1999;8:151-156.
13. Cuadrado MJ, Khamashta M, Hughes GRV. Migraine and stroke in young women. Q J Med. 2000;93:317-319.
14. Hughes GRV. Migraine, memory loss, and "multiple sclerosis," Neurological features of the antiphospholipid (Hughes') syndrome. Postgrad Med J. 2003;79:81-83.
15. Cuadrado MJ, Khamashta MA, Hughes GRV. Sticky blood and headaches. Lupus. 2001;10:392-393.